These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 35484028)

  • 1. Morbidity and mortality in men: Role of androgens.
    Fallara G; Pozzi E; Corsini C; Belladelli F; Boeri L; Capogrosso P; Montorsi F; Salonia A
    Best Pract Res Clin Endocrinol Metab; 2022 Jul; 36(4):101662. PubMed ID: 35484028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic Effects of Testosterone Therapy in Men with Type 2 Diabetes and Metabolic Syndrome.
    Hackett G
    Sex Med Rev; 2019 Jul; 7(3):476-490. PubMed ID: 30803918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular Disease, Hypogonadism and Erectile Dysfunction: Early Detection, Prevention and the Positive Effects of Long-Term Testosterone Treatment: Prospective Observational, Real-Life Data.
    Alwani M; Yassin A; Talib R; Al-Qudimat A; Aboumarzouk O; Al-Zoubi RM; Saad F; Haider KS; Al Ansari A
    Vasc Health Risk Manag; 2021; 17():497-508. PubMed ID: 34465997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular Morbidity and Mortality in Men - Findings From a Meta-analysis on the Time-related Measure of Risk of Exogenous Testosterone.
    Fallara G; Pozzi E; Belladelli F; Corsini C; Boeri L; Capogrosso P; Montorsi F; Salonia A
    J Sex Med; 2022 Aug; 19(8):1243-1254. PubMed ID: 35753891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypogonadal men with moderate-to-severe lower urinary tract symptoms have a more severe cardiometabolic risk profile and benefit more from testosterone therapy than men with mild lower urinary tract symptoms.
    Saad F; Doros G; Haider KS; Haider A
    Investig Clin Urol; 2018 Nov; 59(6):399-409. PubMed ID: 30402573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Male Hypogonadism With Risk of Hospitalization for COVID-19.
    Dhindsa S; Champion C; Deol E; Lui M; Campbell R; Newman J; Yeggalam A; Nadella S; Ahir V; Shrestha E; Kannampallil T; Diwan A
    JAMA Netw Open; 2022 Sep; 5(9):e2229747. PubMed ID: 36053534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term treatment with testosterone undecanoate injections in men with hypogonadism alleviates erectile dysfunction and reduces risk of major adverse cardiovascular events, prostate cancer, and mortality.
    Saad F; Caliber M; Doros G; Haider KS; Haider A
    Aging Male; 2020 Mar; 23(1):81-92. PubMed ID: 30782054
    [No Abstract]   [Full Text] [Related]  

  • 8. Testosterone Therapy in Men With Hypogonadism Prevents Progression From Prediabetes to Type 2 Diabetes: Eight-Year Data From a Registry Study.
    Yassin A; Haider A; Haider KS; Caliber M; Doros G; Saad F; Garvey WT
    Diabetes Care; 2019 Jun; 42(6):1104-1111. PubMed ID: 30862651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Testosterone therapy in prostate cancer: is it still a controversy?
    Bart AS; Van Hoof A; Badre-Hume R; Selvarajah J; Robillard K; Albala DM
    Curr Opin Urol; 2022 Nov; 32(6):598-606. PubMed ID: 36081393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diminished androgen and estrogen receptors and aromatase levels in hypogonadal diabetic men: reversal with testosterone.
    Ghanim H; Dhindsa S; Abuaysheh S; Batra M; Kuhadiya ND; Makdissi A; Chaudhuri A; Dandona P
    Eur J Endocrinol; 2018 Mar; 178(3):277-283. PubMed ID: 29339527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Testosterone and Cardiovascular Risk: Meta-Analysis of Interventional Studies.
    Corona G; Rastrelli G; Di Pasquale G; Sforza A; Mannucci E; Maggi M
    J Sex Med; 2018 Jun; 15(6):820-838. PubMed ID: 29803351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Critical Update of the 2010 Endocrine Society Clinical Practice Guidelines for Male Hypogonadism: A Systematic Analysis.
    Seftel AD; Kathrins M; Niederberger C
    Mayo Clin Proc; 2015 Aug; 90(8):1104-15. PubMed ID: 26205546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Remission of type 2 diabetes following long-term treatment with injectable testosterone undecanoate in patients with hypogonadism and type 2 diabetes: 11-year data from a real-world registry study.
    Haider KS; Haider A; Saad F; Doros G; Hanefeld M; Dhindsa S; Dandona P; Traish A
    Diabetes Obes Metab; 2020 Nov; 22(11):2055-2068. PubMed ID: 32558149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Testosterone and mortality].
    Stárka L
    Vnitr Lek; 2016; 62(9 Suppl 3):127-130. PubMed ID: 27734705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testosterone treatment longer than 1 year shows more effects on functional hypogonadism and related metabolic, vascular, diabetic and obesity parameters (results of the 2-year clinical trial).
    Groti Antonič K; Antonič B; Žuran I; Pfeifer M
    Aging Male; 2020 Dec; 23(5):1442-1454. PubMed ID: 32844712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Men with testosterone deficiency and a history of cardiovascular diseases benefit from long-term testosterone therapy: observational, real-life data from a registry study.
    Haider A; Yassin A; Haider KS; Doros G; Saad F; Rosano GM
    Vasc Health Risk Manag; 2016; 12():251-61. PubMed ID: 27366080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Testosterone deficiency in men with Type 2 diabetes: pathophysiology and treatment.
    Gianatti EJ; Grossmann M
    Diabet Med; 2020 Feb; 37(2):174-186. PubMed ID: 31006133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Major cardiovascular disease risk in men with testosterone deficiency (hypogonadism): appraisal of short, medium and long-term testosterone therapy - a narrative review.
    Traish AM
    Sex Med Rev; 2023 Sep; 11(4):384-394. PubMed ID: 37587664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of Testosterone Therapy in the Setting of Prostate Cancer.
    Rodriguez KM; Pastuszak AW; Khera M
    Curr Urol Rep; 2018 Jun; 19(8):67. PubMed ID: 29961247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Perspective on Middle-Aged and Older Men With Functional Hypogonadism: Focus on Holistic Management.
    Grossmann M; Matsumoto AM
    J Clin Endocrinol Metab; 2017 Mar; 102(3):1067-1075. PubMed ID: 28359097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.